Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$306.88 - $380.0 $306 - $380
-1 Reduced 1.0%
99 $37,000
Q3 2023

Oct 27, 2023

SELL
$315.92 - $397.36 $6,318 - $7,947
-20 Reduced 16.67%
100 $32,000
Q1 2023

May 03, 2023

BUY
$323.56 - $373.36 $6,471 - $7,467
20 Added 20.0%
120 $45,000
Q4 2022

Feb 07, 2023

SELL
$248.67 - $334.17 $5,968 - $8,020
-24 Reduced 19.35%
100 $33,000
Q3 2022

Nov 09, 2022

SELL
$263.81 - $337.27 $1,319 - $1,686
-5 Reduced 3.88%
124 $33,000
Q2 2022

Aug 05, 2022

BUY
$301.4 - $428.42 $904 - $1,285
3 Added 2.38%
129 $40,000
Q1 2022

May 09, 2022

BUY
$379.46 - $424.54 $33,013 - $36,934
87 Added 223.08%
126 $53,000
Q4 2021

Feb 08, 2022

BUY
$373.53 - $434.12 $14,567 - $16,930
39 New
39 $16,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.